Surgical Management of Metastatic Peritoneal or Pleural Disease

Seminars in Oncology

Volumn 34, Issue 3, 2007, Pages 215-225

  Gushchin, Vadim ^a   Demmy, Todd L ^b   Kane III, John M ^b  

^a Institute for Cancer Care at Mercy   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN; TALC;

ABDOMINAL SURGERY; AREA UNDER THE CURVE; ARTICLE; ASCITES TUMOR; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; HUMAN; INTESTINE BYPASS; INTESTINE OBSTRUCTION; OVERALL SURVIVAL; PALLIATIVE THERAPY; PARACENTESIS; PATIENT SELECTION; PERITONEUM METASTASIS; PERITONEUM VEIN SHUNT; PLEURA EFFUSION; PLEURA METASTASIS; PLEURODESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL TIME; THORACOCENTESIS; THORAX DRAINAGE;

ASCITES; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DRAINAGE; HUMANS; INTESTINAL OBSTRUCTION; PALLIATIVE CARE; PERITONEAL NEOPLASMS; PLEURAL EFFUSION; PLEURAL NEOPLASMS; PROGNOSIS; SCLEROTHERAPY;

EID: 34249863577     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.03.009     Document Type: Article

References (105)

1. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
2. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92 (2001) 85-91
3. Adam R.A., and dam Y.G. Malignant ascites: Past, present, and future. J Am Coll Surg 198 (2004) 999-1011
4. Lee C.W., Bociek G., and Faught W. A survey of practice in management of malignant ascites. J Pain Symptom Manage 16 (1998) 96-101
5. Ross G.J., Kessler H.B., Clair M.R., et al. Sonographically guided paracentesis for palliation of symptomatic malignant ascites. AJR Am J Roentgenol 153 (1989) 1309-1311
6. Richard H.M., Coldwell D.M., Boyd-Kranis R.L., et al. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 12 (2001) 373-375
7. Gough I.R., and Balderson G.A. Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management. Cancer 71 (1993) 2377-2382
8. Bieligk S.C., Calvo B.F., and Coit D.G. Peritoneovenous shunting for nongynecologic malignant ascites. Cancer 91 (2001) 1247-1255
9. Orsi F., Della V.P., Penco S., et al. Percutaneous placement of peritoneal port-catheter in oncologic patients. Eur Radiol 14 (2004) 2020-2024
10. Rundback J.H., Gray R.J., Buck D.R., et al. Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy. J Vasc Interv Radiol 5 (1994) 161-165
11. Francois Y., Grandclement E., Sayag-Beaujard A.C., et al. Intraperitoneal chemo-hyperthermia with mitomycin C in cancer of the stomach with peritoneal carcinosis. J Chir (Paris) 134 (1997) 237-242
12. Chang E., Alexander H.R., Libutti S.K., et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 193 (2001) 225-229
13. Garofalo A., Valle M., Garcia J., et al. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol 32 (2006) 682-685
14. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63 (1989) 364-367
15. Blair S.L., Chu D.Z., and Schwarz R.E. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 8 (2001) 632-637
16. Finocchiaro C., Galletti R., Rovera G., et al. Percutaneous endoscopic gastrostomy: A long-term follow-up. Nutrition 13 (1997) 520-523
17. McCarthy J.D. A strategy for intestinal obstruction of peritoneal carcinomatosis. Arch Surg 121 (1986) 1081-1082
18. Glehen O., and Gilly F.N. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin North Am 12 (2003) 649-671
19. Katz M.H., and Barone R.M. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin North Am 12 (2003) 673-688
20. Los G., Mutsaers P.H., van der Vijgh W.J., et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49 (1989) 3380-3384
21. Sticca R.P., and Dach B.W. Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin North Am 12 (2003) 689-701
22. Glehen O., Mithieux F., Osinsky D., et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 21 (2003) 799-806
23. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
24. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
25. Yonemura Y., Bandou E., Kinoshita K., et al. Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin North Am 12 (2003) 635-648
26. Yonemura Y., de Aretxabala X., Fujimura T., et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48 (2001) 1776-1782
27. Turlakow A., Yeung H.W., Salmon A.S., et al. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 44 (2003) 1407-1412
28. de Bree E., Koops W., Kroger R., et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86 (2004) 64-73
29. de Bree E., Koops W., Kroger R., et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32 (2006) 65-71
30. Verwaal V.J., van Tinteren H., Ruth S.V., et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85 (2004) 61-67
31. McQuellon R.P., Loggie B.W., Lehman A.B., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10 (2003) 155-162
32. Glehen O., Cotte E., Schreiber V., et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91 (2004) 747-754
33. Shen P., Hawksworth J., Lovato J., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11 (2004) 178-186
34. Verwaal V.J., van Ruth S., Witkamp A., et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12 (2005) 65-71
35. Stewart J.H., Shen P., Russell G.B., et al. Appendiceal neoplasms with peritoneal dissemination: Outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13 (2006) 624-634
36. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
37. Deraco M., Baratti D., Inglese M.G., et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11 (2004) 393-398
38. Yonemura Y., Kawamura T., Bandou E., et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92 (2005) 370-375
39. Glehen O., Schreiber V., Cotte E., et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139 (2004) 20-26
40. Hirose K., Katayama K., Iida A., et al. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 57 (1999) 106-114
41. Glehen O., Mohamed F., and Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 240 (2004) 278-285
42. Lynch T.J. Management of malignant pleural effusions. Chest 103 suppl (1993) 385S-389S
43. Fiocco M., and Krasna M.J. The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 11 (1997) 253-265
44. Macha H.N., Reichle G., von Zwehl D., et al. The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease. Clinical experience in 687 cases. Eur J Cardiothorac Surg 7 (1993) 19-22
45. Boutin C., Astoul P., and Seitz B. The role of thoracoscopy in the evaluation and management of pleural effusions. Lung 168 suppl (1990) 1113-1121
46. DeCamp Jr. M.M., Jaklitsch M.T., Mentzer S.J., et al. The safety and versatility of video-thoracoscopy: A prospective analysis of 895 consecutive cases. J Am Coll Surg 181 (1995) 113-120
47. Allen M.S., Deschamps C., Jones D.M., et al. Video-assisted thoracic surgical procedures: The Mayo experience. Mayo Clin Proc 71 (1996) 351-359
48. Ryan C.J., Rodgers R.F., Unni K.K., et al. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 56 (1981) 145-149
49. Poe R.H., Levy P.C., Israel R.H., et al. Use of fiberoptic bronchoscopy in the diagnosis of bronchogenic carcinoma. A study in patients with idiopathic pleural effusions. Chest 105 (1994) 1663-1667
50. Chung C.L., Chen Y.C., and Chang S.C. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 123 (2003) 1188-1195
51. Ohm C., Park D., Vogen M., et al. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of malignant pleural effusions. Am Surg 69 (2003) 198-202
52. Putnam J.B., Light R.W., Rodriguez R.M., et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 86 (1999) 1992-1999
53. Robinson R.D., Fullerton D.A., Albert J.D., et al. Use of pleural Tenckhoff catheter to palliate malignant pleural effusion. Ann Thorac Surg 57 (1994) 286-288
54. Chen Y.M., Shih J.F., Yang K.Y., et al. Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients. Support Care Cancer 8 (2000) 423-426
55. Sahin U., Unlu M., Akkaya A., et al. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions. Respiration 68 (2001) 501-505
56. Pollak J.S., Burdge C.M., Rosenblatt M., et al. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 12 (2001) 201-208
57. Cimochowski G.E., Joyner L.R., Fardin R., et al. Pleuroperitoneal shunting for recalcitrant pleural effusions. J Thorac Cardiovasc Surg 92 (1986) 866-870
58. Little A.G., Kadowaki M.H., Ferguson M.K., et al. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg 208 (1988) 443-450
59. Tzeng E., and Ferguson M.K. Predicting failure following shunting of pleural effusions. Chest 98 (1990) 890-893
60. Petrou M., Kaplan D., and Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 75 (1995) 801-805
61. Genc O., Petrou M., Ladas G., et al. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 18 (2000) 143-146
62. Schulze M., Boehle A.S., Kurdow R., et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: Thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 71 (2001) 1809-1812
63. McLoud T.C., Isler R., and Head J. The radiologic appearance of chemical pleurodesis. Radiology 135 (1980) 313-317
64. Lorch D.G., Gordon L., Wooten S., et al. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 93 (1988) 527-529
65. McAlpine L.G., Hulks G., and Thomson N.C. Management of recurrent malignant pleural effusion in the United Kingdom: Survey of clinical practice. Thorax 45 (1990) 699-701
66. Villanueva A.G., Gray Jr. A.W., Shahian D.M., et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 49 (1994) 23-25
67. Ukale V., Bone D., Hillerdal G., et al. The impact of pleurodesis in malignant effusion on respiratory function. Respir Med 93 (1999) 898-902
68. Patz Jr. E.F., McAdams H.P., Goodman P.C., et al. Ambulatory sclerotherapy for malignant pleural effusions. Radiology 199 (1996) 133-135
69. Saffran L., Ost D.E., Fein A.M., et al. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 118 (2000) 417-421
70. Luketich J.D., Kiss M., Hershey J., et al. Chest tube insertion: A prospective evaluation of pain management. Clin J Pain 14 (1998) 152-154
71. Parulekar W., Di Primio G., Matzinger F., et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 120 (2001) 19-25
72. Parker L.A., Charnock G.C., and Delany D.J. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 64 (1989) 1218-1221
73. Clementsen P., Evald T., Grode G., et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter A prospective randomized study. Respir Med 92 (1998) 593-596
74. Hsu W.H., Chiang C.D., Chen C.Y., et al. Ultrasound-guided small-bore Elecath tube insertion for the rapid sclerotherapy of malignant pleural effusion. Jpn J Clin Oncol 28 (1998) 187-191
75. Bethune N. Pleural poudrage: A new technique for deliberate production of pleural adhesions as preliminary to lobectomy. J Thorac Cardiovasc Surg 4 (1935) 251-261
76. Light R.W. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 162 (2000) 2024-2026
77. Rinaldo J.E., Owens G.R., and Rogers R.M. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 85 (1983) 523-526
78. Aelony Y., King R., and Boutin C. Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions. Ann Intern Med 115 (1991) 778-782
79. Danby C.A., Adebonojo S.A., and Moritz D.M. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V. sedation. Chest 113 (1998) 739-742
80. Aelony Y., King R.R., and Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions: Effective pleurodesis despite low pleural pH. Chest 113 (1998) 1007-1012
81. Ohri S.K., Oswal S.K., Townsend E.R., et al. Early and late outcome after diagnostic thoracoscopy and talc pleurodesis. Ann Thorac Surg 53 (1992) 1038-1041
82. Kennedy L., Rusch V.W., Strange C., et al. Pleurodesis using talc slurry. Chest 106 (1994) 342-346
83. Rodriguez-Panadero F. Talc pleurodesis for treating malignant pleural effusions. Chest 108 (1995) 1178-1179
84. Viallat J.R., Rey F., Astoul P., et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 110 (1996) 1387-1393
85. Yim A.P., Chung S.S., Lee T.W., et al. Thoracoscopic management of malignant pleural effusions. Chest 109 (1996) 1234-1238
86. Dresler C.M., Olak J., Herndon J.E., et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 127 (2005) 909-915
87. Robinson L.A., Fleming W.H., and Galbraith T.A. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 55 (1993) 1115-1121
88. Evans T.R., Stein R.C., Pepper J.R., et al. A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer 29A (1993) 316-319
89. Ostrowski M.J., and Halsall G.M. Intracavitary bleomycin in the management of malignant effusions: A multicenter study. Cancer Treat Rep 66 (1982) 1903-1907
90. Emad A., and Rezaian G.R. Treatment of malignant pleural effusions with a combination of bleomycin and tetracycline. A comparison of bleomycin or tetracycline alone versus a combination of bleomycin and tetracycline. Cancer 78 (1996) 2498-2501
91. Jensen M.O., Matthees D.J., and Antonenko D. Laser thoracoscopy for pleural effusion. Am Surg 58 (1992) 667-669
92. Colt H.G., Russack V., Chiu Y., et al. A comparison of thoracoscopic talc insufflation, slurry, and mechanical abrasion pleurodesis. Chest 111 (1997) 442-448
93. Bernard A., de Dompsure R.B., Hagry O., et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 74 (2002) 213-217
94. Soysal O., Karaoglanoglu N., Demiracan S., et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: Results of surgery. Eur J Cardiothorac Surg 11 (1997) 210-213
95. Fry W.A., and Khandekar J.D. Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol 2 (1995) 160-164
96. Martini N., Bains M.S., and Beattie Jr. E.J. Indications for pleurectomy in malignant effusion. Cancer 35 (1975) 734-738
97. van de Molengraft F.J., and Vooijs G.P. Survival of patients with malignancy-associated effusions. Acta Cytol 33 (1989) 911-916
98. Harris R.J., Kavuru M.S., Mehta A.C., et al. The impact of thoracoscopy on the management of pleural disease. Chest 107 (1995) 845-852
99. Irani D.R., Underwood R.D., Johnson E.H., et al. Malignant pleural effusions. A clinical cytopathologic study. Arch Intern Med 147 (1987) 1133-1136
100. Webb W.R., Ozmen V., Moulder P.V., et al. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 103 (1992) 881-885
101. Fukuse T., Hirata T., Tanaka F., et al. The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer. Lung Cancer 34 (2001) 75-81
102. Ichinose Y., Tsuchiya R., Koike T., et al. Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer 32 (2001) 55-60
103. Hillerdal G., Dernevik L., Almgren S.O., et al. Prognostic value of malignant cells in pleural lavage at thoracotomy for bronchial carcinoma. Lung Cancer 21 (1998) 47-52
104. Friedberg J.S., Mick R., Stevenson J.P., et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol 22 (2004) 2192-2201
105. Takita H., Mang T.S., Loewen G.M., et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 58 (1994) 995-998